Illumina's Q1 Revenues Grow 28 Percent | GenomeWeb

This article has been updated to include comments from Illumina's conference call.

NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that its first quarter 2015 revenues grew 28 percent year over year, and on a constant currency basis were up 33 percent.

The San Diego-based firm reported total Q1 2015 revenues of $538.6 million compared to $420.8 million in Q1 2014. It beat the average analyst estimate of $524.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.